Skip to main content
Top
Published in: Gastric Cancer 2/2014

01-04-2014 | Original Article

Treatment selection for gastric cancer with portal hypertension: clinical management

Authors: Zhou-Xiang Jin, Yong-Yong Ma, Xiang-Yu Wang, Li-Jun Li, Zhi-Qiang Zheng

Published in: Gastric Cancer | Issue 2/2014

Login to get access

Abstract

Background

Treatment for gastric cancer with portal hypertension must consider the eradication of the tumor and the change of hemodynamics in portal hypertension (PHT). Few reports have described the surgical procedures and postoperative complications of surgery for gastric cancer associated with PHT.

Methods

The clinical data of 22 patients with PHT undergoing curative surgery for gastric cancer during 5 years were retrospectively analyzed. For 12 patients classified in Child’s class A, D2 lymph node (LN) dissection was performed, and 10 patients classified into Child’s class B were treated with D1 LN dissection. Surgical treatment included total gastrectomy combined with pericardial devascularization, distal subtotal gastrectomy, distal subtotal gastrectomy combined with splenectomy, and distal subtotal gastrectomy combined with pericardial devascularization with posterior gastric artery and left inferior phrenic artery preserved. A liver biopsy was analyzed in all patients.

Results

Postoperative complications developed in 50 % (11/22 patients) and the mortality rate was 9 % (2/22). The rate of postoperative ascites in patients with Child’s class A was much lower than in those with Child’s class B (P < 0.05). “Operation time,” “volume of hemorrhage,” “platelet count,” and “treatment of PHT” are all risk factors of liver function deterioration. However, there was no significant difference in liver function deterioration rate between patients with Child’s class A and Child’s class B (P > 0.05). The occurrence rate of complications in patients with PHT was much higher compared to those without with PHT (P < 0.05).

Conclusions

Individualized selection of surgical approaches is crucial for treatment of gastric carcinoma accompanied by PHT. Surgical treatment should be based on preoperative TNM stage, liver function, and degree of PHT.
Literature
1.
go back to reference Parkin DM, Bray F, Ferlay J, et al. Global cancer statistics, 2002. CA Cancer J Clin. 2005;55:74–108.PubMedCrossRef Parkin DM, Bray F, Ferlay J, et al. Global cancer statistics, 2002. CA Cancer J Clin. 2005;55:74–108.PubMedCrossRef
2.
go back to reference Carrison RN, Cryer HM, Howard DA, et al. Clarification of risk factors for abdominal operations in patients with hepatic cirrhosis. Ann Surg. 1984;199:648–55.CrossRef Carrison RN, Cryer HM, Howard DA, et al. Clarification of risk factors for abdominal operations in patients with hepatic cirrhosis. Ann Surg. 1984;199:648–55.CrossRef
3.
go back to reference Siewert JR, Kestlmeier R, Busch R, et al. Benefits of D2 lymph node dissection for patients with gastric cancer and pN0 and pN1 lymph node metastases. Br J Surg. 1996;83:1144–7.PubMedCrossRef Siewert JR, Kestlmeier R, Busch R, et al. Benefits of D2 lymph node dissection for patients with gastric cancer and pN0 and pN1 lymph node metastases. Br J Surg. 1996;83:1144–7.PubMedCrossRef
4.
go back to reference Isozaki H, Okajima K, Ichinona T, et al. Surgery for gastric cancer in patients with cirrhosis. Surg Today. 1997;27:17–21.PubMedCrossRef Isozaki H, Okajima K, Ichinona T, et al. Surgery for gastric cancer in patients with cirrhosis. Surg Today. 1997;27:17–21.PubMedCrossRef
5.
go back to reference Kumagai K. Intractable ascites following surgery for gastric carcinoma. Dig Surg. 1998;15:236–40.PubMedCrossRef Kumagai K. Intractable ascites following surgery for gastric carcinoma. Dig Surg. 1998;15:236–40.PubMedCrossRef
6.
go back to reference Hyun JJ, Kim JH, Song Hun Ho, et al. Clinical outcomes of patients with liver cirrhosis who underwent curative surgery for gastric cancer: a retrospective multi-center study. Dig Dis Sci. 2008;53:399–404.CrossRef Hyun JJ, Kim JH, Song Hun Ho, et al. Clinical outcomes of patients with liver cirrhosis who underwent curative surgery for gastric cancer: a retrospective multi-center study. Dig Dis Sci. 2008;53:399–404.CrossRef
7.
go back to reference Pugh RN, Murray-Lyon IM, Dawson JL, et al. Transection of the oesophagus for bleeding oesophageal varices. Br J Surg. 1973;60:646–9.PubMedCrossRef Pugh RN, Murray-Lyon IM, Dawson JL, et al. Transection of the oesophagus for bleeding oesophageal varices. Br J Surg. 1973;60:646–9.PubMedCrossRef
8.
go back to reference Japanese Gastric Cancer Association. Japanese classification of gastric carcinoma. 13th ed. Tokyo: Kanehara; 1999. Japanese Gastric Cancer Association. Japanese classification of gastric carcinoma. 13th ed. Tokyo: Kanehara; 1999.
9.
go back to reference Dent DM, Madden MV, Price SK. Randomized comparison of R1 and R2 gastrectomy for gastric carcinoma. Br J Surg. 1988;75:110–2.PubMedCrossRef Dent DM, Madden MV, Price SK. Randomized comparison of R1 and R2 gastrectomy for gastric carcinoma. Br J Surg. 1988;75:110–2.PubMedCrossRef
10.
go back to reference Garrison RN, Cryer HM, Howard DA, et al. Clarification of risk factors for abdominal operations in patients with hepatic cirrhosis. Ann Surg. 1984;199:648–55.PubMedCentralPubMedCrossRef Garrison RN, Cryer HM, Howard DA, et al. Clarification of risk factors for abdominal operations in patients with hepatic cirrhosis. Ann Surg. 1984;199:648–55.PubMedCentralPubMedCrossRef
11.
go back to reference Fekete F, Belghiti J, Cherqui D, et al. Results of esophagogastrectomy for carcinoma in cirrhotic patients. A series of 23 consecutive patients. Ann Surg. 1987;206:74–8.PubMedCentralPubMedCrossRef Fekete F, Belghiti J, Cherqui D, et al. Results of esophagogastrectomy for carcinoma in cirrhotic patients. A series of 23 consecutive patients. Ann Surg. 1987;206:74–8.PubMedCentralPubMedCrossRef
12.
go back to reference Sirinek KR, Burk RR, Brown M, et al. Improving survival in patients with cirrhosis undergoing major abdominal operations. Arch Surg. 1987;122:271–3.PubMedCrossRef Sirinek KR, Burk RR, Brown M, et al. Improving survival in patients with cirrhosis undergoing major abdominal operations. Arch Surg. 1987;122:271–3.PubMedCrossRef
13.
go back to reference Jakab F, Ráth Z, Sugár I, et al. Complications following major abdominal surgery in cirrhotic patients. Hepatogastroenterology. 1993;40:176–9.PubMed Jakab F, Ráth Z, Sugár I, et al. Complications following major abdominal surgery in cirrhotic patients. Hepatogastroenterology. 1993;40:176–9.PubMed
14.
go back to reference Huang PT, Li YP, Zhao YP, et al. Diagnostic value of double contrast-enhanced ultrasonography in preoperative staging of gastric cancer. Chin Ultrasound Imaging J. 2008;1:740–2. Huang PT, Li YP, Zhao YP, et al. Diagnostic value of double contrast-enhanced ultrasonography in preoperative staging of gastric cancer. Chin Ultrasound Imaging J. 2008;1:740–2.
15.
go back to reference Huang PT, Zhao YP, Zheng ZQ, et al. Assessment of gray-scale contrast enhanced ultrasound on liver metastasis of advanced gastric carcinoma. Chin Ultrasound Imaging J. 2009;18:840–2. Huang PT, Zhao YP, Zheng ZQ, et al. Assessment of gray-scale contrast enhanced ultrasound on liver metastasis of advanced gastric carcinoma. Chin Ultrasound Imaging J. 2009;18:840–2.
16.
go back to reference Isozaki H, Okajima K, Ichinona T, et al. Surgery for gastric cancer in patients with cirrhosis. Surg Today. 1997;27:17–21.PubMedCrossRef Isozaki H, Okajima K, Ichinona T, et al. Surgery for gastric cancer in patients with cirrhosis. Surg Today. 1997;27:17–21.PubMedCrossRef
17.
go back to reference Chikamori F, Shibuya S, Takase Y. Percutaneous transhepatic obliteration for esophagojejunal varices after total gastrectomy. Abdom Imaging. 1998;23:560–2.PubMedCrossRef Chikamori F, Shibuya S, Takase Y. Percutaneous transhepatic obliteration for esophagojejunal varices after total gastrectomy. Abdom Imaging. 1998;23:560–2.PubMedCrossRef
18.
go back to reference Zhou YB, Li SK, Zhang JL, et al. The surgical management of advanced gastric carcinoma with portal hypertension. Chin J Gen Surg. 2005;20:406–8. Zhou YB, Li SK, Zhang JL, et al. The surgical management of advanced gastric carcinoma with portal hypertension. Chin J Gen Surg. 2005;20:406–8.
19.
go back to reference Liu CL, Fan ST, Lo CM, et al. Abdominal drainage after hepatic resection is contraindicated in patients with chronic liver diseases. Ann Surg. 2011;239:194–201.CrossRef Liu CL, Fan ST, Lo CM, et al. Abdominal drainage after hepatic resection is contraindicated in patients with chronic liver diseases. Ann Surg. 2011;239:194–201.CrossRef
20.
go back to reference Shi CY, Zhou H, Wu ZY, et al. Surgery for gastric cancer with cirrhosis portal hypertension. Chin J Oper Proced Gen Surg. 2009;3:616–21. Shi CY, Zhou H, Wu ZY, et al. Surgery for gastric cancer with cirrhosis portal hypertension. Chin J Oper Proced Gen Surg. 2009;3:616–21.
21.
go back to reference Zhou BY, Chen SY, Wang H. Analysis of postoperative complications of gastric carcinoma with liver cirrhosis. Chin Surg J. 2008;23:950–2. Zhou BY, Chen SY, Wang H. Analysis of postoperative complications of gastric carcinoma with liver cirrhosis. Chin Surg J. 2008;23:950–2.
Metadata
Title
Treatment selection for gastric cancer with portal hypertension: clinical management
Authors
Zhou-Xiang Jin
Yong-Yong Ma
Xiang-Yu Wang
Li-Jun Li
Zhi-Qiang Zheng
Publication date
01-04-2014
Publisher
Springer Japan
Published in
Gastric Cancer / Issue 2/2014
Print ISSN: 1436-3291
Electronic ISSN: 1436-3305
DOI
https://doi.org/10.1007/s10120-013-0276-4

Other articles of this Issue 2/2014

Gastric Cancer 2/2014 Go to the issue